Bernat Olle, Vedanta | Where is the Microbiome Industry Now and Being a European Entrepreneur in Boston | E04
Listen now
Description
In a virtual special, we welcome Bernat Olle to the show. We discuss the microbiome space, including Vedanta’s upcoming Phase 3, and how it feels to be a European founder in Boston. Bernat is the CEO and co-founder of Boston-based Vedanta Biosciences, one of the leading microbiome companies. They’ve had a positive Phase 2 trial and recently raised a $107M round to run a Phase 3. Bernat is a life science trailblazer. During his doctorate at MIT, he developed a novel method for large-scale bacterial culture. He's been named "Innovator of the Year in MIT Technology Review Spain's "Innovators under 35" awards and even has his own TED Talk! I’ve known Bernat since 2013 when I was studying in Boston and he was starting Vedanta. It was great to catch up again and become inspired once more. ⏰ Timestamps: (00:00:00) Intro (00:00:56) Welcome (00:02:36) Zooming out on the microbiome field (00:11:44) Standardizing the process and composition (00:21:39) What's the cost? (00:27:16) Scalability (00:33:05) The many microbiome companies (00:39:43) EU microbiome industry (00:43:51) Challenge of fundraising (00:49:23) Running a company in the US vs EU (01:00:30) Would you recommend the entrepreneurial path? (01:06:04) What can I do for my microbiome? (01:18:06) Follow Bernat (01:19:09) Wrapping up 📜 Read the full transcript here: https://tinyurl.com/yek8ctss 🔗 Links mentioned: Ep112: Bernat Olle on Microbiome Therapeutics - The Long Run with Like Timmerman - https://timmermanreport.com/2022/04/microbiome-based-drug-development-bernat-olle-on-the-long-run/ Ending the War on Microbes | Bernat Olle | TEDxCambridge : https://www.youtube.com/watch?v=yScP4Cm0-gE&pp=ygUQYmVybmF0IG9sbGUgdGVlZA%3D%3D 🔗 FOLLOW US - Don't miss an episode by signing up for our monthly newsletter: http://eepurl.com/h_fnmH - LinkedIn: https://www.linkedin.com/company/flot-bio/ - Twitter: https://twitter.com/FlotBio 🎙️ ABOUT FLOT.BIO Bringing to your eardrums the top minds of the EU biotech industry, Flot.bio is a podcast for those who are curious. Laidback 1-hour conversations with the most interesting thought leaders in the field, Flot.bio is digging out cool ideas, groundbreaking research, and industry insights to inspire and help you grow in your work (and life). Turn up your speaker and get ready for the latest biotech buzz with your host, Philip Hemme. ⭐️ SPONSORSHIP Ready to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts! 🎧 LISTEN FOR FREE - Spotify: https://tinyurl.com/5n6w7jdu - YouTube: https://youtube.com/@flot.bio. - Apple Podcasts: https://tinyurl.com/5n6w7jdu - or anywhere you get your podcasts... 🙏 LIKE/FOLLOW/REVIEW Did you enjoy the episode? Let us know your thoughts and what you found useful by dropping a comment. Also, make sure you like the episode and follow our channel so you never miss an episode and help others to find it too.
More Episodes
We’re online with Adrian Rawcliffe, the CEO of Adaptimmune, the TCR cell therapy company behind the first engineered cell therapy for solid tumors that was approved for a rare form of sarcoma. We talked about Tecelra's commercial rollout. We also talked about what's next in cell therapy, and...
Published 10/28/24
Published 10/28/24